Self-adjusted postmenopausal hormone replacement therapy: Effects on the biological and immunological profile of FSH and correlation to climacteric symptoms

European Journal of Endocrinology

Volumn 146, Issue 3, 2002, Pages 333-338

  Vihtamäki, Tarja ^a   Simoni, Manuela ^a   Tuimala, Risto ^a   Nieschlag, Eberhard ^a   Vihko, Kimmo K ^a  

^a TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; ESTRADIOL; ESTROGEN; FOLLITROPIN; FOLLITROPIN RECEPTOR; MEGESTROL ACETATE; SEX HORMONE BINDING GLOBULIN;

ADULT; ARTICLE; CLIMACTERIUM; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ADMINISTRATION; ENDOCRINE DISEASE; ESTROGEN THERAPY; FEMALE; FOLLITROPIN BLOOD LEVEL; GENETIC TRANSFECTION; HORMONE DETERMINATION; HUMAN; HYSTERECTOMY; POSTMENOPAUSE; PRIORITY JOURNAL; SCORING SYSTEM; SYMPTOM;

EID: 0036201745     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1460333     Document Type: Article

References (28)

1. The evolution of postmenopausal symptoms
2. The biological basis of the menopause
3. Gonadotropins and gonadotropin receptors during the perimenopause
4. Gonadotropins and ovarian gonadotropin receptors during the perimenopausal transition period
5. Definition and measurement of follicle stimulating hormone
6. Individual hormone replacement therapy
7. Can climacteric women self-adjust therapeutic estrogen doses using symptoms as markers?
8. Heterogeneity of follicle-stimulating hormone: Control and physiological function
9. Follicle stimulating isohormones: Characterization and physiological relevance
10. Circulating bioactive and immunoreactive recombinant human follicle stimulating hormone (Org 32489) after administration to gonadotropin-deficient subjects
11. In vitro bioassay for human follicle-stimulating hormone (FSH) based on L cells transfected with recombinant rat FSH receptor: Validation of a model system
12. Effects of gonadotropin-releasing hormone on bioactivity of follicle-stimulating hormone (FSH) and microstructure of FSH, luteinizing hormone and sex-hormone binding globulin in a testosterone-based trial: Evaluation of responders and non-responders
13. Hormonal characteristics of the human menstrual cycle throughout reproductive life
14. The ratios of serum bioactive/immunoreactive luteinizing hormone and follicle-stimulating hormone in various clinical conditions with Reevaluation by a highly sensitive immunometric assay
15. Differing responses of plasma bioactive and immuno-reactive follicle-stimulating hormone and luteinizing hormone to gonadotropin-releasing hormone antagonist and agonist treatments in postmenopausal women
16. Effects of oestrogen treatment on serum gonadotropin bioactivity, immunoreactivity and isohormone distribution, and on immunoreactive inhibin levels, in prostatic cancer patients
17. Bioassays of gonadotropins based on cloned receptors
18. Bone mass in post-menopausal women after withdrawal of estrogen/gestagen replacement therapy
19. Hot flushes. Estrogen replacement therapy: Indications and complications
20. Hormone therapy to prevent disease and prolong life in postmenopausal women
21. Postmenopausal hormone replacement, risk estimators for coronary artery disease and cardiovascular protection
22. Hormone replacement therapy and prevention of nonvertebral fracture: An analysis of randomized trials
23. Why do postmenopausal women discontinue hormone replacement therapy?
24. Hormone replacement therapy: Clinical benefits and side-effects
25. Long-term effect of transdermal hormonal therapy on aspects of quality of life in post-menopausal women
26. Transdermal oestradiol gel in the treatment of the climacterium: A comparison with oral therapy
27. Impact of percutaneous oestradiol gels in post-menopausal hormone replacement therapy on clinical symptoms and endometrium
28. Menopausal flushes: A neuro-endocrine link with pulsatile luteinizing hormone secretion